In silico analysis of predicted differential MHC binding and CD8+ T-cell immune escape of SARS-CoV-2 B.1.1.529 variant mutant epitopes
Pablo Riesgo-FerreiroiD, Ranganath Gudimella, Thomas BukuriD, Patrick SorniD, Thomas Rösler, Barbara SchrörsiD, Martin Löwer
Abstract
IntroductionThe B.1.1.529 (Omicron) SARS-CoV-2 variant has raised global concerns due to its high number of mutations and its rapid spread. It is of major importance to understand the impact of this variant on the acquired and induced immunity. Several preliminary studies have reported the impact of antibody binding and to this date, there are few studies on Omicrons CD8+ T-cell immune escape. MethodsWe first assessed the impact of Omicron and B.1.617.2 (Delta) variant mutations on the SARS-CoV-2 spike epitopes submitted to the Immune Epitope Database (IEDB) with positive out-come on MHC ligand or T-cell assays (n=411). From those epitopes modified by a mutation, we found the corresponding homologous epitopes in Omicron and Delta. We then ran the netMHCpan computational MHC binding prediction on the pairs of IEDB epitopes and matching homologous epitopes over top 5 MHC I alleles on some selected populations. Lastly, we applied a Fisher test to find mutations enriched for homologous epitopes with decreased predicted binding affinity. ResultsWe found 31 and 78 IEDB epitopes modified by Delta and Omicron mutations, respectively. The IEDB spike protein epitopes redundantly cover the protein sequence. The WT pMHC with a strong predicted binding tend to have homologous mutated pMHC with decreased binding. A similar trend is observed in Delta over all HLA genes, while in Omicron only for HLA-B and HLA-C. Finally, we obtained one and seven mutations enriched for homologous mutated pMHC with decreased MHC binding affinity in Delta and Omicron, respectively. Three of the Omicron mutations, VYY143-145del, K417N and Y505H, are replacing an aromatic or large amino acid, which are reported to be enriched in immunogenic epitopes. K417N is common with Beta variants, while Y505H and VYY143-145del are novel Omicron mutations. ConclusionIn summary, pMHC with Delta and Omicron mutations show decreased MHC binding affinity, which results in a trend specific to SARS-CoV-2 variants. Such epitopes may decrease overall presentation on different HLA alleles suggesting evasion from CD8+ T-cell responses in specific HLA alleles. However, our results show B.1.1.529 (Omicron) will not totally evade the immune system through a CD8+ immune escape mechanism. Yet, we identified mutations in B.1.1.529 (Omicron) introducing amino acids associated with increased immunogenicity. AvailabilityAll the code and results from this study are available at https://github.com/TRON-bioinformatics/omicron-analysis.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 1
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- SARS-CoV-2 Omicron (BA.1 and BA.2) specific novel CD8+ and CD4+ T cell epitopes targeting spike protein.
S. Parn, K. Savsani, S. Dakshanamurthy·bioRxiv·Apr 5, 2022
- In silico analysis predicts a limited impact of SARS-CoV-2 variants on CD8 T cell recognition
O. I. Isaeva, S. L. C. Ketelaars, P. Kvistborg·bioRxiv·Mar 23, 2022
- Alterations in SARS-CoV-2 Omicron and Delta peptides presentation by HLA molecules
S. Nersisyan, A. Zhiyanov, … A. Tonevitsky·bioRxiv·Feb 21, 2022
- Minimal cross-over between mutations associated with Omicron variant of SARS-CoV-2 and CD8+ T cell epitopes identified in COVID-19 convalescent individuals
A. Redd, A. Nardin, … A. A. Tobian·bioRxiv·Dec 6, 2021
- Computational analysis of the effect of SARS-CoV-2 variant Omicron Spike protein mutations on dynamics, ACE2 binding and propensity for immune escape
N. Teruel, M. Crown, … R. Najmanovich·bioRxiv·Dec 14, 2021
- SARS-CoV-2 escapes CD8 T cell surveillance via mutations in MHC-I restricted epitopes
B. Agerer, M. Koblischke, … A. Bergthaler·bioRxiv·Dec 18, 2020